Intramuscular administration of a VEGF zinc finger transcription factor activator (VEGF-ZFP-TF) improves functional outcomes in SOD1 rats

References

• Federici T, Boulis N. Gene-based treatment of motor neuron diseases. Muscle Nerve. 2006;33:302–23.
   PubMed Web of Science ®Google Scholar
• Price D, Becher M, Wong P, Borchelt D, Lee M, Sisodia S. Inherited neurodegenerative diseases and transgenic models. Brain Pathol. 1996;6:467–80.
   PubMedGoogle Scholar
• Bruijn L, Miller T, Cleveland D. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu Rev Neurosci. 2004;27:723–49.
   PubMed Web of Science ®Google Scholar
• Matthews C, Feldman E. Insulin-like growth factor-1 is an osmoprotectant in human neuroblastoma cells. Neuorscience. 1997;79:525–34.
   PubMedGoogle Scholar
• Howland DS, Liu J, She Y, Goad B, Maragakis NJ, Kim B, . Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS). Proc Natl Acad Sci USA. 2002;99:1604–9.
   PubMed Web of Science ®Google Scholar
• Storkebaum E, Lambrechts D, Dewerchin M, Moreno-Murciano MP, Appelmans S, Oh H, . Treatment of motor neuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS. Nat Neurosci. 2005;8:85–92.
   PubMed Web of Science ®Google Scholar
• Matsumoto A, Okada Y, Nakamichi M, Nakamura M, Toyama Y, Sobue G, . Disease progression of human SOD1 (G93A) transgenic ALS model rats. J Neurosci Res. 2006;83:119–33.
   PubMedGoogle Scholar
• Zachary I. Neuroprotective role of vascular endothelial growth factor: signalling mechanisms, biological function, and therapeutic potential. Neurosignals. 2005;14:207–21.
   PubMed Web of Science ®Google Scholar
• Lambrechts D, Storkebaum E, Morimoto M, Del-Favero J, Desmet F, Marklund SL, . VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motor neurons against ischemic death. Nat Genet. 2003; 34:383–94.
   PubMed Web of Science ®Google Scholar
• Brockington A, Wharton SB, Fernando M, Gelsthorpe CH, Baxter L, Ince PG, . Expression of vascular endothelial growth factor and its receptors in the central nervous system in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol. 2006;65:26–36.
   PubMed Web of Science ®Google Scholar
• Barbeito AG, Martinez-Palma L, Vargas MR, Pehar M, Manay N, Beckman JS, . Lead exposure stimulates VEGF expression in the spinal cord and extends survival in a mouse model of ALS. Neurobiol Dis. 2010;37:574–80.
   PubMed Web of Science ®Google Scholar
• Bogaert E, van Damme P, Poesen K, Dhondt J, Hersmus N, Kiraly D, . VEGF protects motor neurons against excitotoxicity by up-regulation of GluR2. Neurobiol Aging. 2010;31:2185–91.
   PubMed Web of Science ®Google Scholar
• Dewil M, Lambrechts D, Sciot R, Shaw PJ, Ince PG, Robberecht W, . Vascular endothelial growth factor counteracts the loss of phospho-Akt preceding motor neuron degeneration in amyotrophic lateral sclerosis. Neuropathol Appl Neurobiol. 2007;33:499–509.
   PubMedGoogle Scholar
• Dodge JC, Treleaven CM, Fidler JA, Hester M, Haidet A, Handy C, . AAV4-mediated expression of IGF-1 and VEGF within cellular components of the ventricular system improves survival outcome in familial ALS mice. Mol Ther. 2010;18:2075–84.
   PubMed Web of Science ®Google Scholar
• Hwang DH, Lee HJ, Park IH, Seok JI, Kim BG, Joo IS, . Intrathecal transplantation of human neural stem cells overexpressing VEGF provide behavioral improvement, disease onset delay and survival extension in transgenic ALS mice. Gene Ther. 2009;16:1234–44.
   PubMed Web of Science ®Google Scholar
• Lunn JS, Sakowski SA, Kim B, Rosenberg AA, Feldman EL. Vascular endothelial growth factor prevents G93A-SOD1-induced motor neuron degeneration. Dev Neurobiol. 2009; 69:871–84.
   PubMedGoogle Scholar
• Tolosa L, Mir M, Asensio VJ, Olmos G, Llado J. Vascular endothelial growth factor protects spinal cord motor neurons against glutamate-induced excitotoxicity via phosphatidylinositol 3-kinase. J Neurochem. 2008;105:1080–90.
   PubMedGoogle Scholar
• Wang Y, Mao XO, Xie L, Banwait S, Marti HH, Greenberg DA, . Vascular endothelial growth factor overexpression delays neurodegeneration and prolongs survival in amyotrophic lateral sclerosis mice. J Neurosci. 2007;27:304–7.
   PubMed Web of Science ®Google Scholar
• Zheng C, Nennesmo I, Fadeel B, Henter JI. Vascular endothelial growth factor prolongs survival in a transgenic mouse model of ALS. Ann Neurol. 2004;56:564–7.
   PubMed Web of Science ®Google Scholar
• Azzouz M, Ralph GS, Storkebaum E, Walmsley LE, Mitrophanous KA, Kingsman SM, . VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model. Nature. 2004;429:413–7.
   PubMed Web of Science ®Google Scholar
• Thoenen H, Sendtner M. Neurotrophins: from enthusiastic expectations through sobering experiences to rational therapeutic approaches. Nat Neurosci. 2002;5 (Suppl):1046–50.
   PubMedGoogle Scholar
• Jamieson AC, Miller JC, Pabo CO. Drug discovery with engineered zinc-finger proteins. Nat Rev Drug Discov. 2003; 2:361–8.
   PubMed Web of Science ®Google Scholar
• Rebar EJ, Huang Y, Hickey R, Nath AK, Meoli D, Nath S, . Induction of angiogenesis in a mouse model using engineered transcription factors. Nat Med. 2002;8:1427–32.
   PubMed Web of Science ®Google Scholar
• Liu PQ, Rebar EJ, Zhang L, Liu Q, Jamieson AC, Liang Y, . Regulation of an endogenous locus using a panel of designed zinc finger proteins targeted to accessible chromatin regions. Activation of vascular endothelial growth factor A. J Biol Chem. 2001;276:11323–34.
   PubMed Web of Science ®Google Scholar
• Sakowski SA, Heavener SB, Lunn JS, Fung K, Oh SS, Spratt SK, . Neuroprotection using gene therapy to induce vascular endothelial growth factor-A expression. Gene Ther. 2009;16:1292–9.
   PubMed Web of Science ®Google Scholar
• Dai Q, Huang J, Klitzman B, Dong C, Goldschmidt-Clermont PJ, March KL, . Engineered zinc finger-activating vascular endothelial growth factor transcription factor plasmid DNA induces therapeutic angiogenesis in rabbits with hindlimb ischemia. Circulation. 2004;110:2467–75.
   PubMed Web of Science ®Google Scholar
• Xie D, Li Y, Reed EA, Odronic SI, Kontos CD, Annex BH. An engineered vascular endothelial growth factor-activating transcription factor induces therapeutic angiogenesis in ApoE knockout mice with hindlimb ischemia. J Vasc Surg. 2006;44:166–75.
   PubMed Web of Science ®Google Scholar
• Price SA, Dent C, Duran-Jimenez B, Liang Y, Zhang L, Rebar EJ, . Gene transfer of an engineered transcription factor promoting expression of VEGF-A protects against experimental diabetic neuropathy. Diabetes. 2006;55: 1847–54.
   PubMed Web of Science ®Google Scholar
• Devos D, Moreau C, Lassalle P, Perez T, de Seze J, Brunaud-Danel V, . Low levels of the vascular endothelial growth factor in CSF from early ALS patients. Neurology. 2004; 62:2127–9.
   PubMed Web of Science ®Google Scholar
• Pawson EJ, Duran-Jimenez B, Surosky R, Brooke HE, Spratt SK, Tomlinson DR, . Engineered zinc finger protein-mediated VEGF-A activation restores deficient VEGF-A in sensory neurons in experimental diabetes. Diabetes. 2010;59:509–18.
   PubMed Web of Science ®Google Scholar
• Liu Y, Figley S, Spratt SK, Lee G, Ando D, Surosky R, . An engineered transcription factor which activates VEGF-A enhances recovery after spinal cord injury. Neurobiol Dis. 2010;37:384–93.
   PubMedGoogle Scholar
• Anonymous. Guide for the Care and Use of Laboratory Animals. Washington, D.C.: National Academy Press; 1996.
   Google Scholar
• Basso D, Beattie M, Bresnahan J. A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma. 1995;12:1–21.
   PubMed Web of Science ®Google Scholar
• Kong J, Xu Z. Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1. J Neurosci. 1998;18: 3241–50.
   PubMed Web of Science ®Google Scholar
• Boulis NM, Turner DE, Imperiale MJ, Feldman EL. Neuronal survival following remote adenovirus gene delivery. J Neurosurg Spine. 2002;96:212–9.
   Google Scholar
• Hashizume K, Kanda K, Burke RE. Medial gastrocnemius motor nucleus in the rat: age-related changes in the number and size of motor neurons. J Comp Neurol. 1988;269: 425–30.
   PubMed Web of Science ®Google Scholar
• Iwasaki Y, Sugimoto H, Ikeda K, Takamiya K, Shiojima T, Kinoshita M. Muscle morphometry in amyotrophic lateral sclerosis. Int J Neurosci. 1991;58:165–70.
   PubMed Web of Science ®Google Scholar
• Krivickas LS, Yang JI, Kim SK, Frontera WR. Skeletal muscle fiber function and rate of disease progression in amyotrophic lateral sclerosis. Muscle Nerve. 2002;26:636–43.
   PubMedGoogle Scholar
• Hegedus J, Putman CT, Gordon T. Time-course of preferential motor unit loss in the SOD1-G93A mouse model of amyotrophic lateral sclerosis. Neurobiol Dis. 2007;28: 154–64.
   PubMed Web of Science ®Google Scholar
• Oosthuyse B, Moons L, Storkebaum E, Beck H, Nuyens D, Brusselmans K, . Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat Genet. 2001;28:131–8.
   PubMed Web of Science ®Google Scholar
• Jin KL, Mao XO, Greenberg DA. Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia. Proc Natl Acad Sci U S A. 2000;97:10242–7.
   PubMed Web of Science ®Google Scholar
• Sondell M, Sundler F, Kanje M. Vascular endothelial growth factor is a neurotrophic factor which stimulates axonal outgrowth through the flk-1 receptor. Eur J Neurosci. 2000; 12:4243–54.
   PubMed Web of Science ®Google Scholar
• Schratzberger P, Walter DH, Rittig K, Bahlmann FH, Pola R, Curry C, . Reversal of experimental diabetic neuropathy by VEGF gene transfer. J Clin Invest. 2001;107:1083–92.
   PubMed Web of Science ®Google Scholar
• Chattopadhyay M, Krisky D, Wolfe D, Glorioso JC, Mata M, Fink DJ. HSV-mediated gene transfer of vascular endothelial growth factor to dorsal root ganglia prevents diabetic neuropathy. Gene Ther. 2005;12:1377–84.
   PubMed Web of Science ®Google Scholar
• Hattori K, Dias S, Heissig B, Hackett NR, Lyden D, Tateno M, . Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. J Exp Med. 2001;193:1005–14.
   PubMed Web of Science ®Google Scholar
• Moore MA, Hattori K, Heissig B, Shieh JH, Dias S, Crystal RG, . Mobilization of endothelial and hematopoietic stem and progenitor cells by adenovector-mediated elevation of serum levels of SDF-1, VEGF, and angiopoietin-1. Ann N Y Acad Sci. 2001;938:36–45; discussion –7.
   PubMed Web of Science ®Google Scholar
• Bogaert E, dan Damme P, van Den Bosch L, Robberecht W. Vascular endothelial growth factor in amyotrophic lateral sclerosis and other neurodegenerative diseases. Muscle Nerve. 2006;34:391–405.
   PubMed Web of Science ®Google Scholar
• Lambrechts D, Carmeliet P. VEGF at the neurovascular interface: therapeutic implications for motor neuron disease. Biochim Biophys Acta. 2006;1762:1109–21.
   PubMed Web of Science ®Google Scholar
• Sathasivam S. VEGF and ALS. Neurosci Res. 2008;62: 71–7.
   PubMed Web of Science ®Google Scholar